Skip to main content
. 2018 May 1;24:2700–2710. doi: 10.12659/MSM.907441

Figure 1.

Figure 1

Some characteristics and differentiation potential of mouse BMSCs and miR-199b-5p expression under different cells and time. (A) The fourth passage of BMSCs (100×). (B, C) β-galactosidase staining at day 1 and day 3 after BMSCs passage (100×). (D) Cell morphology at day 12 with 5-azacytidine treatment (100×). (E) Expression level of miR-199b-5p in BMSCs, 5-azacytidine treated BMSCs at day 12 and cardiomyocytes. (F) Expression level of miR-199b-5p in 5-azacytidine treated BMSCs at 0, 3, 6, 9, 12 days; * p<0.05, n=3.